Trials / Withdrawn
WithdrawnNCT03998605
Protect Yourself: Abuse Prevention for People With Intellectual Disabilities
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Double S Instructonal Systems · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to help individuals and their caregivers develop a plan on how to recognize, deal with and respond to abusive situations.
Detailed description
The goal of this project is to address the current deficiencies by creating a program that will guide individuals who have intellectual disabilities and a Learning Partner (LP - care provider, relative, group home staff) in developing a comprehensive Individual Response Plan (IRP) that can be used before, during, and after an abusive event. Behavioral skills training and behavioral relaxation training -- two instructional approaches with evidence for effectiveness in this population -- will be included to address the unique learning needs of people who have intellectual disabilities and to maximize opportunities for skill-based learning. Video and workbook activities will train the LP to effectively implement the abuse prevention and response strategies, thus increasing the potential for generalization in the natural environment and long-term maintenance of skills.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Abuse Prevention Program | The abuse prevention program will be comprised of nine shared learning modules for the individual with Intellectual Disabilities (ID) and a care provider. Each shared module will contain an action step in the Individual Response Plan and will include video, guided practice and workbook activities to equip persons with ID with a range of judgment, decision-making skills and the efficacy needed for identifying, rejecting, and reporting abuse. |
| BEHAVIORAL | Control Condition | The control group will receive worksheets from the ESCAPE-NOW curriculum. |
Timeline
- Start date
- 2022-10-04
- Primary completion
- 2022-11-30
- Completion
- 2022-12-31
- First posted
- 2019-06-26
- Last updated
- 2023-02-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03998605. Inclusion in this directory is not an endorsement.